omicron | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023

omicron

Omicron subvariant XBB.1: An illustration of the novel coronavirus seen next to a health care worker at a Covid-19 testing centre in New Delhi. (Sanchit Khanna / HT Photo)
Coronavirus chronicle

Omicron subvariant XBB.1.5 may be dominant in Europe soon: Health agency

XBB.1.5 In Europe: The health body said that the risk associated with the subvariant was estimated to be low.

File Photo: Reuters
Covid-19 in Bangladesh

'Covid cases still low but no alternative to caution'

FILE PHOTO: Chinese President Xi Jinping looks on during a meeting with Thai Prime Minister Prayuth Chan-ocha on the sidelines of the Asia-Pacific Economic Cooperation (APEC) summit in Bangkok, Thailand November 19, 2022. REUTERS/Athit Perawongmetha/Pool/File Photo
Coronavirus chronicle

China's Xi told EU less lethal Omicron opens way for fewer Covid restrictions

(Reuters file image)
Covid-19 in Bangladesh

New Omicron sub-variant ‘XBB’ detected in Bangladesh

Omicron subvariant XBB.1: An illustration of the novel coronavirus seen next to a health care worker at a Covid-19 testing centre in New Delhi. (Sanchit Khanna / HT Photo)
Coronavirus chronicle

New Omicron subvariant XBB.1 is ‘strongest by far in vaccine evasion’: Report

A health worker prepares a booster dose of a coronavirus disease (Covid-19) vaccine, as vaccinations jump in Italy after the government made inoculation mandatory for all workers, in Rome, Italy. Photo: Reuters
Coronavirus chronicle

White House urges Covid boosters to protect against spreading BA.5 subvariant

(Reuters file image)
Coronavirus chronicle

Australia expands fourth Covid dose rollout amid fresh Omicron threat

Photo: Collected
Coronavirus chronicle

US medical experts call for Omicron-specific Covid boosters

Illustration: Collected
Covid-19 in Bangladesh

Omicron sub variant dominant in Bangladesh since May : Report

FILE PHOTO: A vial labelled "Sinopharm COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Some Omicron sub-variants escaping antibodies from Sinopharm shot

(Reuters file image)
Coronavirus chronicle

Early Omicron infection unlikely to protect against current variants

(Reuters file image)
World+Biz

Early Omicron infection unlikely to protect against current variants

India's active case count now stands at 3.90 per cent. ( HT file Photo)
Coronavirus chronicle

Omicron less likely to cause long COVID - UK study

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net